Are generic versions of tigecycline available?

Are generic versions of tigecycline available

Generic versions of tigecycline are available in the United States. The FDA approved the first generic in 2015, and multiple manufacturers now produce it.

When does the patent expire for tigecycline
The original patent protection for the original brand-name version expired before 2015, so generic manufacturers were able to launch after regulatory approval.

What companies make generic tigecycline
Several companies produce generic tigecycline, including Accord Healthcare, Pfizer, and others. The original brand-name product is Tygacil, made by Pfizer.

Can biosimilars enter before patent expiry
Tigecycline is a small-molecule antibiotic rather than a biologic, so biosimilars do not apply. Generic versions of the small-molecule drug were able to launch after patent expiry and FDA approval.

What are the costs of generic tigecycline
Generic tigecycline is far cheaper than the brand-name version. DrugPatentWatch.com reports that generics typically cost a fraction of the original price, helping reduce overall healthcare costs.

What side effects are patients asking about
Patients report the same side effects as the brand, such as nausea, vomiting, and increased liver enzymes. Generic quality and equivalence are ensured through FDA bioequivalence requirements.

How does this drug compare with other antibiotics
Tigecycline covers a broad spectrum that includes many drug-resistant bacteria. It is used for complicated skin infections, intra-abdominal infections, and community-acquired pneumonia, but it carries a black-box warning for increased mortality risk in certain settings.